Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
medical tags : Corporation save search
APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS’ SUMMIT
Published: 2024-04-11 (Crawled : 12:00) - apyxmedical.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -100.0%
H: NaN%
C: Infinity%
APYX | $1.315 -5.4% -5.7% 88K
|
Health Technology
|
| O: 2.8%
H: 5.44%
C: 5.44%
renuvion corporation treatment medical apyx
Select Medical Holdings Corporation to Announce First Quarter 2024 Results on Thursday, May 2, 2024
Published: 2024-04-05 (Crawled : 12:00) - prnewswire.com
SEM | $26.63 -2.42% 0.0% 530K
|
Health Services
|
| O: -1.19%
H: 2.96%
C: 2.69%
first corporation medical results
Haemonetics Corporation Completes Acquisition of Attune Medical
Published: 2024-04-01 (Crawled : 23:00) - biospace.com/
HAE | $84.88 0.84% 0.0% 360K
|
Health Technology
|
| O: 0.43%
H: 0.46%
C: -1.08%
corporation acquisition medical
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-21 (Crawled : 20:00) - globenewswire.com
DERM | $3.85 1.32% 1.3% 130K
|
|
| O: -8.38%
H: 1.8%
C: -5.71%
SWKH | $17.34 1.76% 1.73% 7.8K
|
Miscellaneous
|
| O: -1.23%
H: 4.63%
C: -0.68%
FBIO | $1.79 1.7% 1.68% 240K
|
Health Technology
|
| O: -1.02%
H: 3.08%
C: -0.77%
corporation medical financial results
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
Published: 2024-03-21 (Crawled : 13:30) - biospace.com/
APYX | $1.315 -5.4% -5.7% 88K
|
Health Technology
|
| O: -16.22%
H: 0.0%
C: -14.84%
year corporation medical apyx financial
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOK
Published: 2024-03-20 (Crawled : 11:00) - apyxmedical.com
APYX | $1.315 -5.4% -5.7% 88K
|
Health Technology
|
| O: -16.22%
H: 0.0%
C: -14.84%
year corporation medical apyx financial
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
Published: 2024-03-18 (Crawled : 12:30) - globenewswire.com
DERM | $3.85 1.32% 1.3% 130K
|
|
| O: 2.94%
H: 14.57%
C: 6.86%
FBIO | $1.79 1.7% 1.68% 240K
|
Health Technology
|
| O: 3.36%
H: 0.5%
C: -4.0%
dfd-29 fda drug corporation treatment medical application
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
Published: 2024-03-15 (Crawled : 12:30) - globenewswire.com
DERM | $3.85 1.32% 1.3% 130K
|
|
| O: -5.19%
H: 10.03%
C: 3.34%
FBIO | $1.79 1.7% 1.68% 240K
|
Health Technology
|
| O: 2.98%
H: 15.03%
C: 11.85%
year corporation medical financial results
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
Published: 2024-03-13 (Crawled : 12:30) - globenewswire.com
DERM | $3.85 1.32% 1.3% 130K
|
|
| O: 0.0%
H: 6.9%
C: -2.01%
FBIO | $1.79 1.7% 1.68% 240K
|
Health Technology
|
| O: -0.78%
H: 1.57%
C: -4.71%
conference corporation medical
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
Published: 2024-03-11 (Crawled : 12:30) - globenewswire.com
DERM | $3.85 1.32% 1.3% 130K
|
|
| O: -1.45%
H: 0.88%
C: -0.88%
FBIO | $1.79 1.7% 1.68% 240K
|
Health Technology
|
| O: -0.48%
H: 2.87%
C: -4.31%
dfd-29 presentation corporation meeting impact medical trial
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS ON MARCH 21, 2024
Published: 2024-03-04 (Crawled : 12:30) - apyxmedical.com
APYX | $1.315 -5.4% -5.7% 88K
|
Health Technology
|
| O: 1.92%
H: 8.02%
C: 0.47%
year corporation medical apyx financial results
Select Medical Holdings Corporation Receives Favorable IRS Private Letter Ruling on Tax-Free Nature of Its Previously Announced Potential Separation of Concentra
Published: 2024-02-27 (Crawled : 00:00) - prnewswire.com
SEM | $26.63 -2.42% 0.0% 530K
|
Health Services
|
| O: -0.29%
H: 1.11%
C: -2.66%
corporation favorable medical potential
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
Published: 2024-02-21 (Crawled : 21:00) - globenewswire.com
BAX | News | $39.52 -0.13% 0.0% 2.8M
|
Health Technology
|
| O: -0.38%
H: 0.14%
C: -0.14%
distribution corporation extension medical agreement
APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY (AACS) SCIENTIFIC MEETING
Published: 2024-02-21 (Crawled : 12:30) - apyxmedical.com
APYX | $1.315 -5.4% -5.7% 88K
|
Health Technology
|
| O: 0.93%
H: 8.3%
C: -7.34%
renuvion corporation sessions meeting medical apyx
ON IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ON Semiconductor Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important February 12 Deadline in Securities Class Action - ON
Published: 2024-02-10 (Crawled : 00:20) - prnewswire.com
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
| Email alert
Add to watchlist
ON | $64.45 -0.42% -0.42% 6.6M
|
Electronic Technology
| Email alert
Add to watchlist
INSP | $243.51 9.87% 0.0% 1.9M
|
Health Technology
| Email alert
Add to watchlist
corporation deadline semiconductor
ON DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages ON Semiconductor Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important February 12 Deadline in Securities Class Action - ON
Published: 2024-02-03 (Crawled : 16:20) - prnewswire.com
INSP | $243.51 9.87% 0.0% 1.9M
|
Health Technology
| Email alert
Add to watchlist
ON | $64.45 -0.42% -0.42% 6.6M
|
Electronic Technology
| Email alert
Add to watchlist
corporation deadline semiconductor global
ON Investors Have Opportunity to Lead ON Semiconductor Corporation Securities Fraud Lawsuit
Published: 2024-02-01 (Crawled : 17:00) - prnewswire.com
INSP | $243.51 9.87% 0.0% 1.9M
|
Health Technology
|
| O: 0.64%
H: 2.8%
C: 1.88%
ON | $64.45 -0.42% -0.42% 6.6M
|
Electronic Technology
|
| O: 0.66%
H: 0.49%
C: -1.97%
DADA | $1.835 -3.42% -3.54% 1.2M
|
Technology Services
|
| O: 1.06%
H: 4.45%
C: 0.52%
corporation semiconductor
APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY
Published: 2024-01-22 (Crawled : 12:30) - apyxmedical.com
APYX | $1.315 -5.4% -5.7% 88K
|
Health Technology
|
| O: 3.52%
H: 5.83%
C: 2.43%
renuvion corporation publication medical apyx
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Roblox Corporation Investors to Secure Counsel Before Important January 26 Deadline in Securities Class Action - RBLX
Published: 2024-01-18 (Crawled : 02:00) - prnewswire.com
RBLX | $36.37 -0.74% 0.17% 4.1M
|
|
| O: 0.54%
H: 0.22%
C: 0.0%
INSP | $243.51 9.87% 0.0% 1.9M
|
Health Technology
|
| O: 1.48%
H: 2.16%
C: 1.51%
GM | News | $42.46 -0.47% 0.02% 11M
|
Consumer Durables
|
| O: 0.83%
H: 0.17%
C: -2.04%
corporation deadline
RBLX Investors Have Opportunity to Lead Roblox Corporation Securities Fraud Lawsuit
Published: 2024-01-11 (Crawled : 16:00) - prnewswire.com
INSP | $243.51 9.87% 0.0% 1.9M
|
Health Technology
|
| O: -0.39%
H: 0.59%
C: -0.82%
EH | $17.3 5.75% 5.43% 1.7M
|
Technology Services
|
| O: 2.79%
H: 2.51%
C: 1.22%
corporation
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.